Decision Date:
August 2022


RED: NICE TA808 - Fenfluramine is recommended as an add‑on to other anti-seizure medicines for treating seizures associated with Dravet syndrome in people aged 2 years and older,

RED: for treatment of seizures associated with Lennox-Gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients aged ≥2 years. (Decision date -  Sep 2023)

Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
  • 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app